BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

548 related articles for article (PubMed ID: 16981390)

  • 21. [Hypertension in patients with heart failure].
    Takekoshi N; Asaji T; Tada N
    Nihon Rinsho; 2004 Mar; 62 Suppl 3():478-83. PubMed ID: 15171419
    [No Abstract]   [Full Text] [Related]  

  • 22. Analysis of recent papers in hypertension. An angiotensin receptor blocker is more effective than a calcium channel blocker in secondary stroke prevention.
    Bloch MJ; Basile J
    J Clin Hypertens (Greenwich); 2005 Aug; 7(8):489-92. PubMed ID: 16103761
    [No Abstract]   [Full Text] [Related]  

  • 23. [Intervention studies on elderly hypertensive patients in Japan].
    Saito F; Takahashi A; Kushiro T
    Nihon Rinsho; 2005 Jun; 63(6):1078-85. PubMed ID: 15948394
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Pharmacological hypertension therapy].
    Pedersen OL; Christensen KL; Bang LE; Ibsen H; Schultz-Larsen P
    Ugeskr Laeger; 2009 Jun; 171(24):2022-5. PubMed ID: 19523367
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Management of hypertensive patients with cardiovascular damage].
    Tomiyama H; Takata Y; Yamashina A
    Nihon Rinsho; 2004 Mar; 62 Suppl 3():612-6. PubMed ID: 15171444
    [No Abstract]   [Full Text] [Related]  

  • 26. [Old or new antihypertensives--which are better?].
    Schrader J; Kulschewski A
    MMW Fortschr Med; 2005 Mar; 147(13):36-7, 39-40. PubMed ID: 15832760
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Angiotensin II receptor blockers and myocardial infarction: an updated analysis of randomized clinical trials.
    Volpe M; Tocci G; Sciarretta S; Verdecchia P; Trimarco B; Mancia G
    J Hypertens; 2009 May; 27(5):941-6. PubMed ID: 19381108
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Hypertension therapies compared. Are the new nevertheless better than the old?].
    MMW Fortschr Med; 2005 Mar; 147(12):6, 8. PubMed ID: 15832780
    [No Abstract]   [Full Text] [Related]  

  • 29. Effects of eprosartan on target organ protection.
    de la Sierra A
    Vasc Health Risk Manag; 2006; 2(1):79-85. PubMed ID: 17319472
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk reduction by preventing stroke: need for blockade of angiotensin II and catecholamines?
    Rupp H
    Curr Med Res Opin; 2007 Nov; 23 Suppl 5():S25-9. PubMed ID: 18093411
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antihypertensive treatment and development of heart failure in hypertension: a Bayesian network meta-analysis of studies in patients with hypertension and high cardiovascular risk.
    Sciarretta S; Palano F; Tocci G; Baldini R; Volpe M
    Arch Intern Med; 2011 Mar; 171(5):384-94. PubMed ID: 21059964
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Heart failure in hypertension in the elderly].
    Seto S
    Nihon Rinsho; 2005 Jun; 63(6):1041-6. PubMed ID: 15948388
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The ASCOT trial: a closer look.
    Kaplan NM
    J Hypertens; 2006 Feb; 24(2):211-4. PubMed ID: 16508561
    [No Abstract]   [Full Text] [Related]  

  • 34. Comparison between angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on the risk of myocardial infarction, stroke and death: a meta-analysis.
    Reboldi G; Angeli F; Cavallini C; Gentile G; Mancia G; Verdecchia P
    J Hypertens; 2008 Jul; 26(7):1282-9. PubMed ID: 18550998
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Combination therapy with ARB for heart failure].
    Sakata Y
    Nihon Rinsho; 2007 May; 65 Suppl 5():123-7. PubMed ID: 17569310
    [No Abstract]   [Full Text] [Related]  

  • 36. [Effect of antihypertensive drugs of various pharmacological groups on reaction of arterial pressure under conditions of stree testing. Part II. Value of various strategies of potentiation of systemic vasodilatation].
    Praskurnichiĭ EA; Shevchenko OP; Makarova SV; Zhukova VA; Savel'eva SA
    Kardiologiia; 2008; 48(4):18-24. PubMed ID: 18447835
    [No Abstract]   [Full Text] [Related]  

  • 37. Safety and efficacy of first-line antihypertensives.
    Strickland C
    J Fam Pract; 1997 Jun; 44(6):530-1. PubMed ID: 9191619
    [No Abstract]   [Full Text] [Related]  

  • 38. Impact of ASCOT on hypertension treatment and guidelines in older adults.
    Sheridan R; Baldwin N
    Age Ageing; 2006 May; 35(3):214-7. PubMed ID: 16638764
    [No Abstract]   [Full Text] [Related]  

  • 39. Calcium channel blockers: third-line antihypertensives.
    Prescrire Int; 2001 Aug; 10(54):121-3. PubMed ID: 11718186
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Stress-associated hypertension in the work place: results of the STARLET project].
    Lüders S; Hammersen F; Kulschewski A; Frerichs A; Frieg R; Hahnheiser D; Reich G; Schnieders M; Schrandt G; Schrader J
    Dtsch Med Wochenschr; 2006 Nov; 131(46):2580-5. PubMed ID: 17096303
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.